BR0312620A - Derivados de sulfonilpiperidina contendo um grupo arila ou heteroarila para uso como inibidores de metaloproteinase matriz - Google Patents

Derivados de sulfonilpiperidina contendo um grupo arila ou heteroarila para uso como inibidores de metaloproteinase matriz

Info

Publication number
BR0312620A
BR0312620A BR0312620-0A BR0312620A BR0312620A BR 0312620 A BR0312620 A BR 0312620A BR 0312620 A BR0312620 A BR 0312620A BR 0312620 A BR0312620 A BR 0312620A
Authority
BR
Brazil
Prior art keywords
heteroaryl group
aryl
derivatives containing
sulfonylpiperidine
matrix metalloproteinase
Prior art date
Application number
BR0312620-0A
Other languages
English (en)
Inventor
Maurice Raymond Verscho Finlay
Jeremy Nicholas Burrows
Howard Tucker
David Waterson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of BR0312620A publication Critical patent/BR0312620A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

"DERIVADOS DE SULFONILPIPERIDINA CONTENDO UM GRUPO ARILA OU HETEROARILA PARA USO COMO INIBIDORES DE METALOPROTEINASE MATRIZ". A presente invenção se refere a um composto de fórmula (1), onde B representa um grupo arila ou heteroarila monocíclico ou um grupo arila ou heteroarila bicíclico, orto substituído, de utilidade na inibição de uma ou mais metaloproteinases, em particular, da enzima TACE.
BR0312620-0A 2002-07-13 2003-07-09 Derivados de sulfonilpiperidina contendo um grupo arila ou heteroarila para uso como inibidores de metaloproteinase matriz BR0312620A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0216383.0A GB0216383D0 (en) 2002-07-13 2002-07-13 Compounds
PCT/GB2003/002982 WO2004006926A1 (en) 2002-07-13 2003-07-09 Sulphonylpiperidine derivatives containing an aryl or heteroaryl group for use as matrix metalloproteinase inhibitors

Publications (1)

Publication Number Publication Date
BR0312620A true BR0312620A (pt) 2005-04-26

Family

ID=9940463

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0312620-0A BR0312620A (pt) 2002-07-13 2003-07-09 Derivados de sulfonilpiperidina contendo um grupo arila ou heteroarila para uso como inibidores de metaloproteinase matriz

Country Status (16)

Country Link
US (1) US20060173041A1 (pt)
EP (1) EP1539159A1 (pt)
JP (1) JP2006501192A (pt)
CN (1) CN1681503A (pt)
AU (1) AU2003254441A1 (pt)
BR (1) BR0312620A (pt)
CA (1) CA2492086A1 (pt)
GB (1) GB0216383D0 (pt)
IL (1) IL165976A0 (pt)
IS (1) IS7688A (pt)
MX (1) MXPA05000519A (pt)
NO (1) NO20050766L (pt)
PL (1) PL375362A1 (pt)
RU (1) RU2004138546A (pt)
WO (1) WO2004006926A1 (pt)
ZA (1) ZA200500208B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60230781D1 (en) 2001-09-07 2009-02-26 Kaken Pharma Co Ltd Reverse hydroxamsäurederivate
ES2379367T3 (es) 2004-12-21 2012-04-25 Merck Serono Sa Derivados cíclicos de sulfonilamino y uso de los mismos como inhibidores de MMP.
PL1951674T3 (pl) 2005-10-26 2012-04-30 Merck Serono Sa Pochodne sulfonamidowe i ich zastosowania do modulowania metaloproteinaz
NZ620074A (en) * 2009-04-22 2015-09-25 Axikin Pharmaceuticals Inc 2,5-disubstituted arylsulfonamide ccr3 antagonists
EP2554544A1 (en) 2011-08-01 2013-02-06 Almirall, S.A. Pyridin-2(1h)-one derivatives as jak inhibitors
TWI679205B (zh) 2014-09-02 2019-12-11 日商日本新藥股份有限公司 吡唑并噻唑化合物及醫藥

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61501205A (ja) * 1984-02-15 1986-06-19 シェリング・コ−ポレ−ション ８↓−クロル↓−６，１１↓−ジヒドロ↓−１１↓−（４↓−ピペリジリデン）↓−５Ｈ↓−ベンゾ〔５，６〕シクロヘプタ〔１，２−ｂ〕ピリジンおよびその塩、これらの化合物の製造方法、ならびにこれらの化合物を含有する医薬組成物
KR100609926B1 (ko) * 1997-11-12 2006-08-04 다윈 디스커버리 리미티드 엠엠피와 티엔에프 억제 활성을 갖는 히드록삼산 및카르복실산 유도체
EP1107953A1 (en) * 1998-08-29 2001-06-20 British Biotech Pharmaceuticals Limited Hydroxamic acid derivatives as proteinase inhibitors
GB9919776D0 (en) * 1998-08-31 1999-10-27 Zeneca Ltd Compoujnds
CA2409035A1 (en) * 2000-05-15 2001-11-22 Darwin Discovery Limited Hydroxamic acid derivatives

Also Published As

Publication number Publication date
AU2003254441A1 (en) 2004-02-02
PL375362A1 (en) 2005-11-28
GB0216383D0 (en) 2002-08-21
MXPA05000519A (es) 2005-03-23
ZA200500208B (en) 2005-10-20
US20060173041A1 (en) 2006-08-03
EP1539159A1 (en) 2005-06-15
JP2006501192A (ja) 2006-01-12
IS7688A (is) 2005-02-08
NO20050766L (no) 2005-04-11
WO2004006926A1 (en) 2004-01-22
CN1681503A (zh) 2005-10-12
RU2004138546A (ru) 2005-09-10
IL165976A0 (en) 2006-01-15
CA2492086A1 (en) 2004-01-22

Similar Documents

Publication Publication Date Title
BRPI0206433B8 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0506843A (pt) composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto
BRPI0512676B8 (pt) derivados de indolil alquil amina substituídos como inibidores de histona desacetilase, composição farmacêutica que os compreende, seus processos de preparação e uso
BR0208104A (pt) Inibidores de metaloproteinase
BR0314275A (pt) Derivados de hidantoina e seu uso como inibidores de tace
NO20075647L (no) Kjemiske forbindelser
DK1206467T3 (da) N-heterocykliske derivater som NOS-inhibitorer
NO20071504L (no) Pyrimidinderivanter.
DE69809187D1 (de) Metalloproteinase-Inhibitoren
UY29479A1 (es) Inhibidores de adn-pk
NI200700289A (es) Derivados de piridona para modular el sistema de proteína cinasa activada por estrés
BR0207985A (pt) Inibidores de metaloproteinase
WO2008109181A3 (en) Metalloprotease inhibitors containing a heterocyclic moiety
NO20054787L (no) Indenderivater som farmasotiske midler
NO20061317L (no) Imidazopyridinderivater som induserbare NO-syntaseinhibatorer
MX2007007025A (es) Nuevos derivados de hidantoina como inhibidores de metaloproteinasa.
SE0400850D0 (sv) Novel Compounds
ATE502940T1 (de) Ä2,6-ünaphthyridine als proteinkinasehemmer
BRPI0413094A (pt) derivados de quinolina e seu uso em terapia
ATE495158T1 (de) Substituierte tetrahydroisochinoline als mmp- inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament
BR0317284A (pt) Inibidores aminocianopiridina de proteìna quinase-2 ativada com proteìna quinase ativada com mitógeno
BRPI0411308A8 (pt) Composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto
BR0312620A (pt) Derivados de sulfonilpiperidina contendo um grupo arila ou heteroarila para uso como inibidores de metaloproteinase matriz
NO20061316L (no) Imidazopyndinderivater som induserbare NO-syntaseinhibitorer
NO20023951L (no) Arylpiperaziner og arylpiperidiner og deres anvendelse som metalloproteinaseinhiberende midler

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]